UnityPoint Health Ventures

UnityPoint Health Ventures, established in 2019, serves as the corporate venture capital arm of UnityPoint Health, headquartered in West Des Moines, Iowa. The organization focuses on investing in early-stage companies within the healthcare sector, including areas such as digital therapeutics, health information technology, tech-enabled services, medical devices, and diagnostics. UnityPoint Health Ventures is dedicated to fostering innovation that enhances the patient and provider experience, seeking partnerships that align with its mission to improve healthcare delivery and accessibility.

16 past transactions

TailorMed

Series B in 2024
TailorMed Medical Ltd., established in 2017 and based in Tel Aviv, Israel, specializes in health IT solutions. The company develops and provides financial navigation technology and systems, designed to streamline and automate financial processes for both patients and healthcare providers. Their offerings include TailorMed Financial Navigation, a platform to manage and automate financial processes; TailorMed Financial Insights, an analytics and reporting dashboard to track and measure key performance indicators; and TailorMed Pharmacy, a platform to simplify drug ordering, tracking, and billing based on patient treatment regimens.

OpenLoop Health

Series A in 2023
OpenLoop Health is a technology company that provides a comprehensive infrastructure for digital healthcare, enabling healthcare organizations to enhance their service delivery. The company offers a full-stack platform that simplifies telehealth by centralizing essential services, including clinician support, laboratory services, medication management, and regulatory compliance. OpenLoop's solutions are designed to assist healthcare companies in scaling their virtual care services effectively, addressing staff shortages by maintaining an updated provider database and facilitating job matching based on location and specialty. This streamlined approach supports healthcare institutions in efficiently meeting their staffing needs while ensuring high-quality patient care.

Cardiosense

Series A in 2022
Cardiosense is a company that focuses on developing a physiological waveform AI platform aimed at creating predictive biomarkers for disease detection and treatment. By mining raw biosignals, Cardiosense provides enhanced visibility into cardiac functions and employs advanced signal processing techniques to identify pre-symptomatic markers of cardiac disease. The company specializes in utilizing non-invasive sensors and proprietary algorithms, which allow healthcare professionals to monitor and analyze cardiac health signals effectively. This innovative approach enables the early detection of diseases, thereby facilitating improved patient care and health tracking.

Pathware

Series A in 2022
Pathware Inc. is a technology company focused on revolutionizing healthcare through its automated point-of-care biopsy assessment system. The company’s flagship product, Bioptic, empowers clinicians and technicians to diagnose pathogens effectively, enhancing the accuracy and speed of disease diagnosis. Pathware also develops a sample management platform that streamlines pathology workflows, minimizes redundancies, and eliminates the need to send samples to central laboratories. This digital pathology platform features innovative hardware and software tools, including AI-powered image analysis and telepathology capabilities, which allow clinicians to scan, visualize, and analyze tissue samples directly in their clinics. Founded in 2017 and headquartered in Ann Arbor, Michigan, with an additional location in Seattle, Washington, Pathware aims to improve patient care and save lives by facilitating earlier and more precise diagnoses and treatments.

Prolucent

Series A in 2021
Prolucent Health specializes in technology and services aimed at optimizing healthcare workforce management. The company offers a platform that leverages artificial intelligence and advanced analytics to address labor needs through data-driven decision-making. By modernizing recruitment and improving the utilization and cost of healthcare labor, Prolucent enables employers to effectively manage both full-time and contingent workforce components. Additionally, the platform engages healthcare workers, helping them discover suitable job opportunities.

b.well Connected Health

Series B in 2021
b.well Connected Health, Inc. is a healthcare technology company based in Baltimore, Maryland, with an additional office in Austin, Texas. Founded in 2015, the company has developed an application that aggregates and analyzes consumers' healthcare data, enabling users to store, manage, and share medical records and family health history in one accessible platform. The application provides insights into financial aspects of healthcare, including benefit plan details, co-pays, and deductibles, while also integrating data from wearables and other health applications to monitor aspects such as sleep, fitness, and nutrition. b.well Connected Health primarily serves health plans, health systems, employers, and pharmaceutical companies, offering an integrated solution for consumer engagement, holistic health management, and cost containment, ultimately empowering users to optimize their healthcare experience.

TailorMed

Venture Round in 2021
TailorMed Medical Ltd., established in 2017 and based in Tel Aviv, Israel, specializes in health IT solutions. The company develops and provides financial navigation technology and systems, designed to streamline and automate financial processes for both patients and healthcare providers. Their offerings include TailorMed Financial Navigation, a platform to manage and automate financial processes; TailorMed Financial Insights, an analytics and reporting dashboard to track and measure key performance indicators; and TailorMed Pharmacy, a platform to simplify drug ordering, tracking, and billing based on patient treatment regimens.

DocStation

Seed Round in 2021
DocStation, Inc. is a cloud-based patient care platform headquartered in Austin, Texas, that was established in 2017. The company focuses on connecting payers and pharmacists to facilitate value-based care programs, which aim to reduce healthcare costs and enhance patient outcomes. Its platform equips pharmacists with essential tools, including a comprehensive dashboard that consolidates patient information such as diagnoses, medications, immunizations, allergies, and adverse events. This integration allows pharmacists to create care plans, set goals, monitor patient adherence, and schedule follow-ups, thereby enabling real-time connections with patients. With over 500 providers collaborating with innovative health plans on the platform, DocStation is positioned to transform the pharmacy landscape by aligning the interests of all stakeholders involved in patient care.

SilverCloud Health

Series B in 2020
SilverCloud Health, established in 2011, is a digital health company that develops and provides online therapeutic solutions via tailored clinical programs. Headquartered in Boston, Massachusetts, with offices in Dublin, Ireland, and London, UK, the company's SilverCloud platform offers evidence-based, supported digital therapies to various healthcare sectors. It aims to increase client/patient engagement and reduce program dropout rates, as demonstrated by a three-fold improvement in these metrics compared to leading online therapeutic products.

Bright.md

Series C in 2020
Bright.md Inc. is a healthcare technology company based in Portland, Oregon, focused on developing software solutions for the diagnosis and treatment of low-acuity medical conditions. The company offers SmartExam, an AI-powered virtual care platform that enables patients to receive online care for common health concerns without the need for video consultations. By partnering with leading healthcare organizations, Bright.md provides access to its services for over 10 million patients seeking urgent and primary care from their own devices. The platform facilitates efficient care navigation, triage, and treatment options, allowing patients to address their health needs asynchronously and conveniently. Founded in 2012 as Bright Health Solutions LLC, the company aims to modernize telehealth services for healthcare systems, effectively creating a virtual front door for patient care.

VIDA

Series C in 2020
VIDA is a lung health company that modernizes respiratory care by leveraging artificial intelligence to enhance patient outcomes and streamline care coordination. The company provides healthcare organizations and physicians with advanced quantitative data intelligence and impactful visualizations, enabling effective management of patients with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and COVID-19. VIDA's software is FDA cleared, CE-marked, Health Canada licensed, and TGA registered, allowing for clinical use in the United States, European Economic Area, Canada, and Australia. Additionally, VIDA offers a comprehensive suite of clinical trial services, which includes advanced quantitative image analysis and support for trial data enhancement, site quality services, and subject screening, thus contributing to the acceleration of new therapies for patients.

b.well Connected Health

Series A in 2020
b.well Connected Health, Inc. is a healthcare technology company based in Baltimore, Maryland, with an additional office in Austin, Texas. Founded in 2015, the company has developed an application that aggregates and analyzes consumers' healthcare data, enabling users to store, manage, and share medical records and family health history in one accessible platform. The application provides insights into financial aspects of healthcare, including benefit plan details, co-pays, and deductibles, while also integrating data from wearables and other health applications to monitor aspects such as sleep, fitness, and nutrition. b.well Connected Health primarily serves health plans, health systems, employers, and pharmaceutical companies, offering an integrated solution for consumer engagement, holistic health management, and cost containment, ultimately empowering users to optimize their healthcare experience.

CareSignal

Venture Round in 2020
CareSignal is a remote patient monitoring platform designed to enhance the performance of payers and providers in value-based care by focusing on patient engagement and early risk identification. The platform utilizes device-less technology to reach large patient populations through disease-specific, evidence-based automated communications, including text messages and phone calls. It enables care teams to receive real-time alerts that facilitate timely prioritization and proactive outreach. CareSignal is particularly committed to supporting underserved populations and safety-net providers, ensuring that patients can interact with the system using their existing phones. This approach helps care teams address chronic, behavioral, and social challenges faced by patients, promoting better health outcomes.

Kaizen Health

Series B in 2020
Kaizen Health, Inc. is a healthcare mobility company based in Chicago, Illinois, founded in 2015. The company has developed a web-based platform that connects healthcare providers with transportation services, aiming to eliminate transportation as a barrier to accessing healthcare. By facilitating rides to and from medical appointments, Kaizen Health serves a diverse clientele, including healthcare systems, pharmaceutical companies, payers, in-home healthcare services, and senior living facilities. Its technology enhances communication between patients, providers, and transportation services, ensuring that patients, particularly those from low-income, aging, disabled, and veteran communities, receive timely reminders about their appointments and transportation arrangements. By addressing social determinants of health, Kaizen Health promotes health equity and improves access to quality care across various segments of the healthcare industry.

CareSignal

Seed Round in 2019
CareSignal is a remote patient monitoring platform designed to enhance the performance of payers and providers in value-based care by focusing on patient engagement and early risk identification. The platform utilizes device-less technology to reach large patient populations through disease-specific, evidence-based automated communications, including text messages and phone calls. It enables care teams to receive real-time alerts that facilitate timely prioritization and proactive outreach. CareSignal is particularly committed to supporting underserved populations and safety-net providers, ensuring that patients can interact with the system using their existing phones. This approach helps care teams address chronic, behavioral, and social challenges faced by patients, promoting better health outcomes.

VIDA

Corporate Round in 2019
VIDA is a lung health company that modernizes respiratory care by leveraging artificial intelligence to enhance patient outcomes and streamline care coordination. The company provides healthcare organizations and physicians with advanced quantitative data intelligence and impactful visualizations, enabling effective management of patients with chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and COVID-19. VIDA's software is FDA cleared, CE-marked, Health Canada licensed, and TGA registered, allowing for clinical use in the United States, European Economic Area, Canada, and Australia. Additionally, VIDA offers a comprehensive suite of clinical trial services, which includes advanced quantitative image analysis and support for trial data enhancement, site quality services, and subject screening, thus contributing to the acceleration of new therapies for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.